Enantiomers of 2-[(acylamino)ethyl]-1,4-benzodiazepines, potent ligands of κ-opioid receptor:: Chiral chromatographic resolution, configurational assignment, and biological activity

被引:8
作者
Azzolina, O
Collina, S
Linati, L
Anzini, M
Cappelli, A
Scheideler, MA
Sbacchi, M
机构
[1] Univ Pavia, Dipartimento Chim Farmaceut, I-27100 Pavia, Italy
[2] Univ Pavia, Ctr Grandi Strumenti, I-27100 Pavia, Italy
[3] Univ Catanzaro Magna Grecia, Dipartimento Sci Farmacobiol, Catanzaro, Italy
[4] Univ Siena, Dipartimento Farm Chim Tecnol, I-53100 Siena, Italy
[5] SmithKline Beecham, Dept Neurosci, Neurobiol Res, Milan, Italy
关键词
tifluadom analogs; opioid receptor ligands; enantiomer separation; semipreparative chiral chromatography; circular dichroism; H-1-COSY; NOESY spectroscopy;
D O I
10.1002/chir.1185
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Compounds 2a and 3a-e are racemic 2-[(acylamino)ethyl]-1,4-benzodiazepines, tifluadom analogs, with high affinity and selectivity towards the kappa -opioid receptor. We describe the enantiomeric separation of all compounds through liquid chromatography with chiral stationary phases, as well as the resolution of the enantiomers of the most interesting compounds, 2a and 3a, by the semipreparative column Chiralpak AD. The configuration of the resolved enantiomers was investigated: the comparative study of CID and H-1 NMR spectra shows that compounds (-)-2a and (-)-3a have the same absolute configuration of (+)-(S)-tifluadom. A study on the stereoselective interaction with opiate receptors is reported. Chirality 13:606-612, 2001. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:606 / 612
页数:7
相关论文
共 19 条
[1]   CHIRAL RECOGNITION OF ALKYL 2-ARYLOXYPROPIONATES BY HPLC [J].
AZZOLINA, O ;
COLLINA, S .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1995, 18 (01) :81-92
[2]  
Azzolina O, 1997, CHIRALITY, V9, P681, DOI 10.1002/(SICI)1520-636X(1997)9:7<681::AID-CHIR8>3.0.CO
[3]  
2-A
[4]   CHOLECYSTOKININ-A RECEPTOR LIGANDS BASED ON THE KAPPA-OPIOID AGONIST TIFLUADOM [J].
BOCK, MG ;
DIPARDO, RM ;
EVANS, BE ;
RITTLE, KE ;
WHITTER, WL ;
VEBER, DF ;
FREIDINGER, RM ;
CHANG, RSL ;
CHEN, TB ;
LOTTI, VJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (01) :450-455
[5]   [H-3]-LABELED TIFLUADOM BINDING IN GUINEA-PIG BRAIN MEMBRANES [J].
BURKARD, WP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 97 (3-4) :337-338
[6]   Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors [J].
Cappelli, A ;
Anzini, M ;
Vomero, S ;
Menziani, MC ;
DeBenedetti, PG ;
Sbacchi, M ;
Clarke, GD ;
Mennuni, L .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (04) :860-872
[7]   TIFLUADOM, A KAPPA-OPIATE AGONIST, ACTS AS A PERIPHERAL CHOLECYSTOKININ RECEPTOR ANTAGONIST [J].
CHANG, RSL ;
LOTTI, VJ ;
CHEN, TB ;
KEEGAN, ME .
NEUROSCIENCE LETTERS, 1986, 72 (02) :211-214
[8]   THE BENZODIAZEPINE (+)-TIFLUADOM (KC-6128), BUT NOT ITS OPTICAL ISOMER (KC-5911) INDUCES OPIOID KAPPA RECEPTOR-RELATED EEG POWER SPECTRA AND EVOKED-POTENTIAL CHANGES [J].
FREYE, E ;
BOECK, G ;
SCHAAL, M ;
CIARAMELLI, F .
PHARMACOLOGY, 1986, 33 (05) :241-248
[9]   TIFLUADOMS EFFECTS UNDER ELECTRIC-SHOCK TITRATION AND TAIL-IMMERSION PROCEDURES IN SQUIRREL-MONKEYS [J].
GENOVESE, RF ;
DYKSTRA, LA .
LIFE SCIENCES, 1986, 39 (19) :1713-1719
[10]  
Ghislandi V, 1999, CHIRALITY, V11, P21, DOI 10.1002/(SICI)1520-636X(1999)11:1<21::AID-CHIR4>3.0.CO